(Although the approval of the monoclonal antibody teplizumab in 2022, which has recently shown promise as a potential cure for Type 1 diabetes, could cut the rate among all age groups.) As such, while GLP-1s support weight management, they should not be considered a cure-all for overall health or other disease states
You may be eligible if you: Are anywhere from 12 to 17 years of age Either: Have obesity, as defined by BMI equal to or above the 95th percentile for age and sex
Compounded prescriptions, under the right care, could get you where you want to go
Market Access and Patient Services folks, which lever has the best shot at closing this gap: better persistence, reaching maintenance dose, or reducing cost and coverage friction
Whether you are using semaglutide , tirzepatide drops , or a multi-compound GLP-1 oral liquid , the technique principles remain the same
In contrast, people who used a placebo (inactive treatment) only lost around 6 lbs